{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:08:29Z","timestamp":1793376509821,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Microbiol"],"DOI":"10.1007\/s10123-025-00727-7","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T06:46:44Z","timestamp":1759214804000},"page":"2749-2761","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combating multidrug-resistant uropathogenic E. coli using lytic phages, enhancing antibiotic synergy and inhibiting biofilms"],"prefix":"10.1007","volume":"28","author":[{"given":"Md","family":"Shamsuzzaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"727_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.23851\/MJS.V34I1.1243","volume":"34","author":"AA Abdulhussein","year":"2023","unstructured":"Abdulhussein AA, Abdulsattar BO (2023) Identification and characterization of a bacteriophage with lytic activity against multidrug resistant E. coli. Al-Mustansiriyah J Sci 34:24\u201331. https:\/\/doi.org\/10.23851\/MJS.V34I1.1243","journal-title":"Al-Mustansiriyah J Sci"},{"key":"727_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/CID\/CIAE229","author":"SL Aitken","year":"2024","unstructured":"Aitken SL, Pierce VM, Pogue JM (2024) The growing threat of NDM-producing Escherichia coli with penicillin-binding protein 3 mutations in the United States\u2014is there a potential role for durlobactam? Clin Infect Dis. https:\/\/doi.org\/10.1093\/CID\/CIAE229","journal-title":"Clin Infect Dis"},{"key":"727_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1089\/MDR.2022.0228","volume":"29","author":"A Amaro","year":"2023","unstructured":"Amaro A, Le\u00e3o C, Guerra V et al (2023) Plasmid-mediated colistin resistance genes mcr-1 and mcr-4 in multidrug-resistant Escherichia coli strains isolated from a healthy pig in Portugal. Microb Drug Resist 29:78\u201384. https:\/\/doi.org\/10.1089\/MDR.2022.0228","journal-title":"Microb Drug Resist"},{"key":"727_CR4","doi-asserted-by":"publisher","unstructured":"Azam AH, Sato K, Miyanaga K, et al (2024) Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy. Microbiol Spectr 12:. https:\/\/doi.org\/10.1128\/SPECTRUM.00427-23\/SUPPL_FILE\/SPECTRUM.00427-23-S0001.DOCX","DOI":"10.1128\/SPECTRUM.00427-23\/SUPPL_FILE\/SPECTRUM.00427-23-S0001.DOCX"},{"key":"727_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/JACAMR\/DLAF121","author":"YJ Choi","year":"2025","unstructured":"Choi YJ, Shamsuzzaman M, Lee JE (2025a) In vivo pharmacokinetics, therapeutic efficacy and immune response of bacteriophage vB_AbaSt_W16 against carbapenem-resistant Acinetobacter baumannii. JAC-Antimicrobial Resistance. https:\/\/doi.org\/10.1093\/JACAMR\/DLAF121","journal-title":"JAC-Antimicrobial Resistance"},{"key":"727_CR6","doi-asserted-by":"publisher","DOI":"10.1128\/SPECTRUM.00855-25","author":"Y-J Choi","year":"2025","unstructured":"Choi Y-J, Shamsuzzaman M, Park C et al (2025b) Overcoming phage resistance: efficacy of sequential phage-colistin therapy against carbapenem-resistant Acinetobacter baumannii. Microbiol Spectr. https:\/\/doi.org\/10.1128\/SPECTRUM.00855-25","journal-title":"Microbiol Spectr"},{"key":"727_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/J.1365-2672.2004.02422.X","volume":"98","author":"K Dabrowska","year":"2005","unstructured":"Dabrowska K, Swita\u0142a-Jelen K, Opolski A et al (2005) Bacteriophage penetration in vertebrates. J Appl Microbiol 98:7\u201313. https:\/\/doi.org\/10.1111\/J.1365-2672.2004.02422.X","journal-title":"J Appl Microbiol"},{"key":"727_CR8","doi-asserted-by":"publisher","unstructured":"Dhungana G, Nepal R, Houtak G, et al (2023) Characterization and preclinical in silico safety assessment of three virulent bacteriophages targeting carbapenem-resistant uropathogenic Escherichia coli. https:\/\/doi.org\/10.20944\/PREPRINTS202311.0329.V1","DOI":"10.20944\/PREPRINTS202311.0329.V1"},{"key":"727_CR9","doi-asserted-by":"publisher","DOI":"10.5455\/JAVAR.2022.I613","volume":"9","author":"MH Effendi","year":"2022","unstructured":"Effendi MH, Hartadi EB, Witaningrum AM et al (2022) Molecular identification of blaTEM gene of extended-spectrum beta-lactamase-producing Escherichia coli from healthy pigs in Malang district, East Java, Indonesia. J Adv Vet Anim Res 9:447. https:\/\/doi.org\/10.5455\/JAVAR.2022.I613","journal-title":"J Adv Vet Anim Res"},{"key":"727_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PBIO.3002119","volume":"21","author":"AP Fabijan","year":"2023","unstructured":"Fabijan AP, Iredell J, Danis-Wlodarczyk K et al (2023) Translating phage therapy into the clinic: recent accomplishments but continuing challenges. PLoS Biol 21:e3002119. https:\/\/doi.org\/10.1371\/JOURNAL.PBIO.3002119","journal-title":"PLoS Biol"},{"key":"727_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/S00253-018-9471-X\/METRICS","volume":"103","author":"Y Gu","year":"2019","unstructured":"Gu Y, Xu Y, Xu J et al (2019) Identification of novel bacteriophage vB_EcoP-EG1 with lytic activity against planktonic and biofilm forms of uropathogenic Escherichia coli. Appl Microbiol Biotechnol 103:315\u2013326. https:\/\/doi.org\/10.1007\/S00253-018-9471-X\/METRICS","journal-title":"Appl Microbiol Biotechnol"},{"key":"727_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/BTT.S381237","volume":"16","author":"Z Hibstu","year":"2022","unstructured":"Hibstu Z, Belew H, Akelew Y, Mengist HM (2022) Phage therapy: a different approach to fight bacterial infections. Biologics 16:173\u2013186. https:\/\/doi.org\/10.2147\/BTT.S381237","journal-title":"Biologics"},{"issue":"1","key":"727_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/PH12010035","volume":"12","author":"P Hyman","year":"2019","unstructured":"Hyman P (2019) Phages for phage therapy: isolation, characterization, and host range breadth. Pharmaceuticals 12(1):35. https:\/\/doi.org\/10.3390\/PH12010035","journal-title":"Pharmaceuticals"},{"key":"727_CR14","doi-asserted-by":"publisher","unstructured":"Jako\u010di D, Un\u02d9 E Id (2018) Moodley A A rapid bacteriophage DNA extraction method. https:\/\/doi.org\/10.3390\/mps1030027","DOI":"10.3390\/mps1030027"},{"key":"727_CR15","doi-asserted-by":"publisher","unstructured":"Jariremombe RC, Jariremombe RC (2022) Mechanisms of antimicrobial resistance of E. coli. Escherichia coli - old and new insights. https:\/\/doi.org\/10.5772\/INTECHOPEN.101671","DOI":"10.5772\/INTECHOPEN.101671"},{"key":"727_CR16","doi-asserted-by":"publisher","unstructured":"Jnani D, Ray SD (2023) Escherichia coli infection. EOT, Fourth Edition: 1\u20139 4:V4\u2013357-V4\u2013367. https:\/\/doi.org\/10.1016\/B978-0-12-824315-2.00190-1","DOI":"10.1016\/B978-0-12-824315-2.00190-1"},{"key":"727_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/SPECTRUM.00889-23","author":"P Khunti","year":"2023","unstructured":"Khunti P, Chantakorn K, Tantibhadrasapa A et al (2023) A novel coli myophage and antibiotics synergistically inhibit the growth of the uropathogenic E. coli strain CFT073 in stoichiometric niches. Microbiol Spectr. https:\/\/doi.org\/10.1128\/SPECTRUM.00889-23","journal-title":"Microbiol Spectr"},{"issue":"4","key":"727_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.5578\/MB.20239944","volume":"57","author":"SG Kili\u00e7","year":"2023","unstructured":"Kili\u00e7 SG, \u00d6cal D, Tekeli A, Dolap\u00e7i \u0130 (2023) Investigation of virulence factors, phylogenetic group features, and the presence of ST131 clone in Escherichia coli isolates, a urinary tract infection agent in children. Mikrobiyol Bul 57(4):535\u2013552. https:\/\/doi.org\/10.5578\/MB.20239944","journal-title":"Mikrobiyol Bul"},{"key":"727_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/S12275-018-8310-1","volume":"56","author":"S Kim","year":"2018","unstructured":"Kim S, Kim SH, Rahman M, Kim J (2018) Characterization of a Salmonella enteritidis bacteriophage showing broad lytic activity against Gram-negative enteric bacteria. J Microbiol 56:917\u2013925. https:\/\/doi.org\/10.1007\/S12275-018-8310-1","journal-title":"J Microbiol"},{"key":"727_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/CID\/CIAA1031","volume":"73","author":"AP Kourtis","year":"2021","unstructured":"Kourtis AP, Sheriff EA, Weiner-Lastinger LM et al (2021) Antibiotic multidrug resistance of Escherichia coli causing device- and procedure-related infections in the United States reported to the National Healthcare Safety Network, 2013\u20132017. Clin Infect Dis 73:e4552\u2013e4559. https:\/\/doi.org\/10.1093\/CID\/CIAA1031","journal-title":"Clin Infect Dis"},{"key":"727_CR21","doi-asserted-by":"publisher","unstructured":"Krusche J, Beck C, Lehmann E, et al (2024) Systematic classification of phage receptor-binding proteins predicts surface glycopolymer structure in Staphylococcus pathogens. bioRxiv 2024.03.04.583386. https:\/\/doi.org\/10.1101\/2024.03.04.583386","DOI":"10.1101\/2024.03.04.583386"},{"key":"727_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4292\/WJGPT.V8.I3.162","volume":"8","author":"DM Lin","year":"2017","unstructured":"Lin DM, Koskella B, Lin HC (2017) Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther 8:162. https:\/\/doi.org\/10.4292\/WJGPT.V8.I3.162","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"727_CR23","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1016\/J.APSB.2022.05.007","volume":"12","author":"H Ling","year":"2022","unstructured":"Ling H, Lou X, Luo Q et al (2022) Recent advances in bacteriophage-based therapeutics: insight into the post-antibiotic era. Acta Pharm Sin B 12:4348\u20134364. https:\/\/doi.org\/10.1016\/J.APSB.2022.05.007","journal-title":"Acta Pharm Sin B"},{"key":"727_CR24","doi-asserted-by":"publisher","unstructured":"Liu CM, Stegger M, Aziz M, et al (2018) Escherichia coli ST131-H22 as a foodborne uropathogen. mBio 9:. https:\/\/doi.org\/10.1128\/MBIO.00470-18\/SUPPL_FILE\/MBO004184016SD2.XLSX","DOI":"10.1128\/MBIO.00470-18\/SUPPL_FILE\/MBO004184016SD2.XLSX"},{"key":"727_CR25","doi-asserted-by":"publisher","unstructured":"Liu CG, Green SI, Min L, et al (2020) Phage-antibiotic synergy is driven by a unique combination of antibacterial mechanism of action and stoichiometry. mBio 11:1\u201319. https:\/\/doi.org\/10.1128\/MBIO.01462-20\/SUPPL_FILE\/MBIO.01462-20-SF005.TIF","DOI":"10.1128\/MBIO.01462-20\/SUPPL_FILE\/MBIO.01462-20-SF005.TIF"},{"key":"727_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/J.CIS.2017.05.014","volume":"249","author":"DJ Malik","year":"2017","unstructured":"Malik DJ, Sokolov IJ, Vinner GK et al (2017) Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interface Sci 249:100\u2013133. https:\/\/doi.org\/10.1016\/J.CIS.2017.05.014","journal-title":"Adv Colloid Interface Sci"},{"key":"727_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/J.VIRUSRES.2021.198496","volume":"302","author":"S Malik","year":"2021","unstructured":"Malik S, Nehra K, Rana JS (2021) Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli. Virus Res 302:198496. https:\/\/doi.org\/10.1016\/J.VIRUSRES.2021.198496","journal-title":"Virus Res"},{"key":"727_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/FEMSML\/UQAE003","author":"CE Martinez-Soto","year":"2024","unstructured":"Martinez-Soto CE, McClelland M, Kropinski AM et al (2024) Multi-receptor phage cocktail against Salmonella enterica to circumvent phage resistance. microLife. https:\/\/doi.org\/10.1093\/FEMSML\/UQAE003","journal-title":"microLife"},{"key":"727_CR29","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/JEQ2.20459","volume":"52","author":"E Ochirbat","year":"2023","unstructured":"Ochirbat E, Zbonikowski R, Sulicka A et al (2023) Heteroaggregation of virions and microplastics reduces the number of active bacteriophages in aqueous environments. J Environ Qual 52:665\u2013677. https:\/\/doi.org\/10.1002\/JEQ2.20459","journal-title":"J Environ Qual"},{"key":"727_CR30","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/INFDIS\/JIW632","volume":"215","author":"F Oechslin","year":"2017","unstructured":"Oechslin F, Piccardi P, Mancini S et al (2017) Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence. J Infect Dis 215:703\u2013712. https:\/\/doi.org\/10.1093\/INFDIS\/JIW632","journal-title":"J Infect Dis"},{"key":"727_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/ANNUREV-VIROLOGY-012423-110530","volume":"10","author":"A Orom\u00ed-Bosch","year":"2023","unstructured":"Orom\u00ed-Bosch A, Antani JD, Turner PE (2023) Developing phage therapy that overcomes the evolution of bacterial resistance. Annu Rev Virol 10:503\u2013524. https:\/\/doi.org\/10.1146\/ANNUREV-VIROLOGY-012423-110530","journal-title":"Annu Rev Virol"},{"key":"727_CR32","doi-asserted-by":"publisher","unstructured":"Phuong LNN, Anh LH, Huan PKN, et al (2022) The effect of different media and temperature conditions for Salmonella bacteriophage preservation. Vet Integr Sci 20:489\u2013496. https:\/\/doi.org\/10.12982\/VIS.2022.036","DOI":"10.12982\/VIS.2022.036"},{"key":"727_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/MICROBIOLSPEC.ARBA-0026-2017","author":"L Poirel","year":"2018","unstructured":"Poirel L, Madec J-Y, Lupo A et al (2018) Antimicrobial resistance in Escherichia coli. Microbiol Spectr. https:\/\/doi.org\/10.1128\/MICROBIOLSPEC.ARBA-0026-2017","journal-title":"Microbiol Spectr"},{"key":"727_CR34","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/08927014.2011.631169","volume":"27","author":"M Rahman","year":"2011","unstructured":"Rahman M, Kim S, Kim SM et al (2011) Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Biofouling 27:1087\u20131093. https:\/\/doi.org\/10.1080\/08927014.2011.631169","journal-title":"Biofouling"},{"key":"727_CR35","doi-asserted-by":"publisher","DOI":"10.1089\/FPD.2024.0023","author":"M Shamsuzzaman","year":"2024","unstructured":"Shamsuzzaman M, Kim S, Choi Y-J et al (2024a) Therapeutic phage candidates for targeting prevalent sequence types of carbapenem-resistant Escherichia coli. Foodborne Pathog Dis. https:\/\/doi.org\/10.1089\/FPD.2024.0023","journal-title":"Foodborne Pathog Dis"},{"key":"727_CR36","doi-asserted-by":"publisher","first-page":"1455710","DOI":"10.3389\/FMICB.2024.1455710\/BIBTEX","volume":"15","author":"M Shamsuzzaman","year":"2024","unstructured":"Shamsuzzaman M, Kim S, Kim J (2024b) Bacteriophage as a novel therapeutic approach for killing multidrug-resistant Escherichia coli ST131 clone. Front Microbiol 15:1455710. https:\/\/doi.org\/10.3389\/FMICB.2024.1455710\/BIBTEX","journal-title":"Front Microbiol"},{"key":"727_CR37","doi-asserted-by":"publisher","unstructured":"Shamsuzzaman M, Choi YJ, Kim S, Kim J (2025a) Characterization and genome analyses of the novel phages targeting extraintestinal Escherichia coli clones ST131 and ST410. Int Microbio 1\u201313. https:\/\/doi.org\/10.1007\/S10123-025-00686-Z\/FIGURES\/7","DOI":"10.1007\/S10123-025-00686-Z\/FIGURES\/7"},{"key":"727_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/J.JGAR.2025.04.005","author":"M Shamsuzzaman","year":"2025","unstructured":"Shamsuzzaman M, Kim S, Kim J (2025b) Therapeutic potential of novel phages with antibiotic combinations against ESBL-producing and carbapenem-resistant Escherichia coli. J Glob Antimicrob Resist. https:\/\/doi.org\/10.1016\/J.JGAR.2025.04.005","journal-title":"J Glob Antimicrob Resist"},{"key":"727_CR39","doi-asserted-by":"publisher","unstructured":"Shamsuzzaman M, Kim S, Choi Y-J et al (2024) Therapeutic phage candidates for targeting prevalent sequence types of carbapenem-resistant Escherichia coli. https:\/\/home.liebertpub.com\/fpd. https:\/\/doi.org\/10.1089\/FPD.2024.0023","DOI":"10.1089\/FPD.2024.0023"},{"key":"727_CR40","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1089\/MDR.2020.0505","volume":"27","author":"M Taati Moghadam","year":"2021","unstructured":"Taati Moghadam M, Mirzaei M, Fazel Tehrani Moghaddam M et al (2021) The challenge of global emergence of novel colistin-resistant Escherichia coli ST131. Microb Drug Resist 27:1513\u20131524. https:\/\/doi.org\/10.1089\/MDR.2020.0505","journal-title":"Microb Drug Resist"},{"key":"727_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2023.1091442","volume":"14","author":"Z Tang","year":"2023","unstructured":"Tang Z, Tang N, Wang X et al (2023) Characterization of a lytic Escherichia coli phage CE1 and its potential use in therapy against avian pathogenic Escherichia coli infections. Front Microbiol 14:1091442. https:\/\/doi.org\/10.3389\/FMICB.2023.1091442","journal-title":"Front Microbiol"},{"key":"727_CR42","doi-asserted-by":"publisher","DOI":"10.5772\/INTECHOPEN.101583","author":"W Ullah","year":"2023","unstructured":"Ullah W, Ali S (2023) Antimicrobial resistance in Escherichia coli. Escherichia Coli - Old and New Insights. https:\/\/doi.org\/10.5772\/INTECHOPEN.101583","journal-title":"Escherichia Coli - Old and New Insights"},{"key":"727_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOFLM.2023.100155","volume":"6","author":"D Wang","year":"2023","unstructured":"Wang D, Naqvi STA, Lei F et al (2023) Glycosyl hydrolase from Pseudomonas fluorescens inhibits the biofilm formation of pseudomonads. Biofilm 6:100155. https:\/\/doi.org\/10.1016\/J.BIOFLM.2023.100155","journal-title":"Biofilm"},{"key":"727_CR44","doi-asserted-by":"publisher","DOI":"10.1039\/c9np00050j","author":"Y Yan","year":"2020","unstructured":"Yan Y, Liu N, Tang Y (2020) Recent developments in self-resistance gene directed natural product discovery. Nat Prod Rep. https:\/\/doi.org\/10.1039\/c9np00050j","journal-title":"Nat Prod Rep"},{"key":"727_CR45","doi-asserted-by":"publisher","unstructured":"Yoo S, Lee K-M, Kim N, et al (2023) Designing phage cocktails to combat the emergence of bacteriophage-resistant mutants in multidrug-resistant Klebsiella pneumoniae. Microbiol Spectr 12:. https:\/\/doi.org\/10.1128\/SPECTRUM.01258-23","DOI":"10.1128\/SPECTRUM.01258-23"}],"container-title":["International Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10123-025-00727-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10123-025-00727-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10123-025-00727-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:02:27Z","timestamp":1766516547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10123-025-00727-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["727"],"URL":"https:\/\/doi.org\/10.1007\/s10123-025-00727-7","relation":{},"ISSN":["1618-1905"],"issn-type":[{"value":"1618-1905","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}